Prosecution Insights
Last updated: April 19, 2026

Millennium Pharmaceuticals Inc.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
2
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18731923 ADMINISTRATION OF AURORA KINASE INHIBITOR AND CHEMOTHERAPEUTIC AGENTS WHITE, DAWANNA SHAR-DAY 1627 Non-Final OA Jun 03, 2024
17919952 LIPID COMPOSITIONS FOR DELIVERY OF STING AGONIST COMPOUNDS AND USES THEREOF PACKARD, BENJAMIN J 1612 Non-Final OA Oct 19, 2022
17906438 DEVICES AND METHODS FOR TREATING A FISTULA SHARMA, YASHITA 3774 Final Rejection Sep 15, 2022
17655541 METHODS FOR THE TREATMENT OF CHRONIC POUCHITIS HADDAD, MAHER M 1641 Non-Final OA Mar 18, 2022
17604324 ALPHA4BETA7 INHIBITOR AND IL-23 INHIBITOR COMBINATION THERAPY PETERS, ALEC JON 1641 Final Rejection Oct 15, 2021
16608895 METHOD OF TREATING PEDIATRIC DISORDERS HADDAD, MAHER M 1641 Non-Final OA Oct 28, 2019

Managing Millennium Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month